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Mycobacterium tuberculosis owes its high pathogenic potential to its ability to evade host immune
responses and thrive inside the macrophage. The outcome of infection is largely determined by the cellular
response comprising amultitude ofmolecular events. The complexity and inter-relatedness in the processes
makes it essential to adopt systems approaches to study them. In this work, we construct a comprehensive
network of infection-related processes in a human macrophage comprising 1888 proteins and 14,016
interactions. We then compute response networks based on available gene expression profiles
corresponding to states of health, disease and drug treatment. We use a novel formulation for mining
response networks that has led to identifying highest activities in the cell. Highest activity paths provide
mechanistic insights into pathogenesis and response to treatment. The approach used here serves as a
generic framework for mining dynamic changes in genome-scale protein interaction networks.
M ycobacterium tuberculosis (M.tb) kills about 1.5 million people every year and has often been proclaimedas one of the most efficient pathogens known toman1.M.tb has developed strategies not merely to evadehost immune responses but in fact to reside and thrive inside host macrophages. The interactions
between the host and pathogen are indeed known to be multi-faceted, involving many feed-back, feed-forward,
inhibitory and activatory control structures2. The dynamics of interactions between the host and pathogen form a
complex web and determine the outcome of an infection. A systems approach is thus essential to comprehend the
significance of the multiple events that occur simultaneously, including moves and counter-moves of host and
pathogen. The study of host-pathogen interactions has been an area of interest for many pathogens and has been
studied through a variety of approaches3–7.
Several studies of the host transcriptome in response toM.tb and other infectious agents are increasingly being
reported in literature in recent years8–12. Gene expression studies provide lists of differentially expressed genes
(DEGs) in a particular condition, but will not provide answers to why or how such an output results. In order to
further our understanding and gain mechanistic insights into the causes and consequences of such differential
regulation, a systems approach is essential. In a nutshell, the interactions and influences among the various
molecular components in a system ought to be captured using a suitable method of abstraction and analysed as a
whole13.
Interaction networks are useful in this regard, and help understand the various connections that exist in a cell.
Networkmodelling has been extensively used in the analysis of biological systems, where the system ismapped on
to graphical structures and is a well established field in its own right14,15. Networks based on experimentally known
protein-protein interactions (PPIs) and theoretically predicted interactions are available for several organisms
including different human cell types16,17. These networks can provide an overview of the topological architecture
in a cell. However, a drawback of this approach is that networks are static snapshots at a given instant of time and
they do not readily capture the dynamics that occur in the cell, and hence cannot by themselves explain cellular
responses to perturbations such as infections.
The insufficiencies of both approaches can be overcome by integrating genome-wide gene expression profiles
into genome scale molecular networks and constructing a specific network for each cellular condition18. A
protein-protein interaction network by itself is analogous to a street map of a city, while the expression data is
analogous to having the types and the numbers of active vehicles in the city at a given time point. The two types of
data are clearly complementary to each other and provide different perspectives of essentially the same system. If
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integrated together by superimposing gene expression or proteo-
mic data onto topological networks, the insights they can provide
will be significantly greater than what either of them can provide
individually.
Here, we seek to model the flow of information in response to
tuberculosis (TB) infection. Relating to the same analogy, the object-
ive of this work would be comparable to looking for ‘highest vehicu-
lar activities’ in a city’s roads upon a particular trigger. We apply
graph theoreticalmethods to reconstruct weighted directed networks
by integrating ‘omics’ data from tuberculosis patients available in
literature with a curated large scale model and identify ‘highest activ-
ity’ paths in the cell.
Results
We first reconstructed an elaborate model of the macrophage upon
exposure toM.tb to capture important functional processes and their
interconnections including pathogen uptake, consequent signalling
and activation of the appropriate immune response. Macrophages
are constituents of peripheral blood mononuclear cells (PBMCs),
which also include dendritic cells and lymphocytes. This constructed
generic model of the macrophage is largely applicable to PBMCs as
well. Gene expression data from clinical TB patient samples was then
taken from literature to construct specific response networks.
Dynamic changes occurring upon infection and over the course of
treatment with drugs were captured and compared with appropriate
healthy controls to identify routes or paths with highest activities in
these conditions.
A general extensive molecular systems model of the macrophage.
Contact of M.tb with the host occurs in the lungs, and alveolar
macrophages along with neutrophils and lung dendritic cells (DCs)
are the first host cells to interact with M.tb. They secrete several
cytokines, chemokines and produce antibacterial peptides upon
infection. These initial innate immune responders subsequently
govern the activation of T cells, components of the adaptive
immune response. Under the influence of the cytokine IL12 and
chemokines CCL19 and CCL21, M.tb infected DCs migrate to lung
draining lymph nodes and drive the differentiation of naive T cells to
the Th1 phenotype19. After approximately two weeks of initial
infection, antigen-specific Th1 cells migrate back to the lungs under
chemokine influence and mount a protective response by producing
IFN-c20, resulting in macrophage activation leading to augmented
cytokine and chemokine production, release of reactive oxygen
intermediates (ROIs) and reactive nitrogen intermediates (RNIs), as
well as other effector molecules21–23. The T cell dependent response
comprises CD41 and CD81 T cells which recognise antigenic
peptides on MHC class II and MHC class I molecules respectively,
as well as CD1 restricted T cells that recognise glycolipids present in
mycobacterial cell walls. cd T cells, an independent lymphocyte
population, are CD31 T cells which recognise antigens indepen-
dently of specific presentation molecules. Along with DCs, cd T
cells participate in the early immune response to M.tb and produce
pro-inflammatory cytokines such as IFN-c and TNF-a24. Thus, the
components of the innate immune system are key elements in
initiating and influencing the ensuing adaptive response that
mediates protective immunity against M.tb infection25.
We constructed a network model of the processes triggered in the
macrophage in response to tubercular infection, based on an extens-
ive literature survey. The model captures responses in the macro-
phage, commencing with phagocytosis involving the uptake ofM.tb
or mycobacterial components mediated by different surface recep-
tors on the macrophage for both opsonised and non-opsonised bac-
teria. Some of the receptors include complement receptors (for e.g.
CR1, CR3), mannose receptors (MR), type A scavenger receptors
(e.g. SR-A1, SR-A2) and surfactant-protein A (SP-A)26. The immune
response put forward by the phagocyte is dictated by the receptor
involved in M.tb uptake. Uptake ofM.tb by CR1 has been shown to
provide a better chance for pathogen survival than by CR3 or CR427.
Mycobacterial uptake in the presence of surfactant-protein A or
through mannose receptors renders the bacteria better poised to
repress reactive nitrogen intermediates and reactive oxygen species
respectively, both of which are major methods of mycobacterial
elimination by the macrophage27. The nature of interactions of the
receptors with M.tb is thus complex and dynamic, not only being
responsible for uptake but also for triggering or inhibiting cellular
signalling networks that mediate processes of bacterial elimination.
The molecular details of these processes are derived from several
experiments that typically use non phagocytic cells transfected with
the receptors of interest28,29. In the real scenario, however, the uptake
by phagocytes and the downstream events depends upon a number
of aspects including ratios of receptor abundances available on the
phagocyte cell surface, and their relative strengths to recognise
pathogenic molecules, thus making it important to study the system
as a whole.
Different signalling mechanisms such as calcium and phosphoi-
nositide signalling are activated upon binding of M.tb to the macro-
phage, which regulate cytoskeleton rearrangement as well as vesicular
trafficking resulting in the formation of the phagosome30,31. The pha-
gosome then acquires the early and late endosome markers, followed
by fusion with the lysosome to form the phagolysosome32. Fusion
with the lysosome leads to bacterial death, and subsequent process-
ing and presentation of antigens through the MHC presentation
pathway23.The antigens presented are recognised by T cell receptors,
co-stimulatory molecules (CD80/CD86) and adhesion molecules
(intracellular adhesion molecule ICAM-1)23. T cell activation is cent-
ral to the protective immunity to M.tb infection, and cytokines play
an important role in driving T cell differentiation33. Interleukin-12
(IL-12) stimulates the formation of Th1 cells whereas interleukin-4
(IL-4) triggers the formation of Th2 cells34,35. These Th cells release
cytokines having varying effects: the Th1 related cytokines (for e.g.
IFN-c, TNF-a, IL-2) are pro-inflammatory cytokines (PICs), while
Th2 related cytokines (for e.g. IL-4, IL-5, IL-10, IL-13) are generally
anti-inflammatory in nature (anti-inflammatory cytokines or
AICs)33–35. Acute cytokine responses ensue upon M.tb infection of
macrophages, triggered through phagocytic and non-phagocytic
interactions and M.tb components. As the immune response devel-
ops over time, the cytokine and chemokine profiles show variation,
and their activity may be beneficial or detrimental depending on their
relative times of production36. Cytokines and chemokines may act
synergistically or antagonistically. Generally, Th1 related cytokines
mediate protective response to M.tb, while Th2 responses regulate
and inhibit Th1 responses. Th2 related cytokines can also inhibit the
production of chemokines produced by the macrophages37,38.
Chemokines are major signalling molecules responsible for the pro-
gress of inflammation, regulating lymphocyte infiltration and stimu-
lating trans-endothelial migration of T lymphocytes39. The interplay
between PICs, AICs, chemokines and regulatory cytokines is thus
significant in governing the outcome of disease.
Many mycobacterial components trigger or inhibit the host res-
ponse towards elimination of M.tb, enabling bacterial survival.
Mycobacterial cell wall components Lipoarabinomannan (LAM),
Mannosylated LAMs (ManLAM), Phosphatidylinositol Mannoside
(PIM) and Trehalose 6,69-dimycolate (TDM) are the major modu-
lators of phagosome maturation and other signalling pathways40–42.
ManLAM prevents fusion of mycobacterial phagosome with the late
endosome and lysosome by inhibiting the Calmodulin-Ca21 phos-
photidol-inositol-3 kinase43. PIM promotes the interaction and
fusion of mycobacterial phagosome with early endosome, so as to
deliver nutrients tomycobacterial phagosome andmaintain the non-
acidic pH44. TDM also inhibits phospholipid vesicle fusion45.
ManLAM activates host p38MAPK and PPAR signalling pathways
that activate prostaglandin E2 (PGE2), bringing about inhibition of
www.nature.com/scientificreports
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Th1 response, ROI, NF-kB, and activation of Th2 response leading to
the formation of alternatively activated macrophages46. LAM acti-
vates TLR2/1 and brings about the expression of PICs via the tran-
scription factor NF-kB42. LAM is also known to activate ERK1/2
MAPK pathway thereby leading to activation of ROI and RNI42.
TLR activated NF-kBmediates synthesis ofWNT5A which interacts
with FZD5, regulating the microbial-induced IL-12 production in a
paracrine manner, thereby activating T cells that are primed specif-
ically for IFN-gamma release47,48. M.tb also regulates host antigen
presentation49.
The immune response to M.tb is complex and involves various
host and bacterial factors, as well as multiple signalling pathways and
heavy cross-talk between them. While the model presented here
describes the general processes triggered in response to M.tb infec-
tion, it is still an oversimplified depiction of the components and
their complex interactions in the macrophage. Nevertheless, the
model captures the essence of biological processes important for
host-pathogen interactions and presents a framework to study it
from a systems perspective. The model is amenable to expansion
and inclusion of transcriptomic data as it becomes available.
Figure 1 (a) provides a schematic representation of the model
comprising the biological processes or modules triggered in response
toM.tb infection as described, and these host-pathogen interactions
collectively dictate the consequences of infection. The model consti-
tutes 1888 proteins from 32 modules that capture the different cel-
lular signalling processes described above. The distribution of
proteins in the 32 modules is shown in Figure 1 (b). We then derived
a network of interactions of these proteins based on experimental
evidence from literature and several protein-protein interaction
databases. Directionality was assigned to the edges wherever applic-
able based on known experimental information. The final curated
network comprises 1888 nodes (proteins) and 14016 edges (protein-
protein interactions). Of these, 11,283 edges were assigned direction,
while the remaining 2733 interactions were kept as bidirectional
(The final list of interactions along with information of their sources
and direction are given in the supplementary table S1).
Topological network analysis indicated that the network was
scale-free, allowing the identification of highly connected ‘hub’
nodes50. The edge-betweenness, an important measure of centrality
for edges in the network was computed and considered for further
analysis (Network properties are given in Supplementary table S3).
Response networks indicate differential enrichment of modules.
Recent genome-wide transcriptional studies have contributed to our
current understanding of tuberculosis-specific responses in the host.
To this end, a study by Berry et al. (2010)8 reported significant
differences in gene expression values of several genes across diffe-
rent conditions of disease and treatment. The authors identified a
signature of 86 differentially expressed genes unique to tuberculosis
infection. More importantly, a clustering analysis of the profiles was
able to group healthy samples separately from the disease samples,
while also illustrating that the expression profile of the 12 month
drug treated samples was closer to that of healthy controls than active
disease. It is thus clear that the observed gene expression changes are
specific and characteristic of the condition. Microarray analysis
however, is insufficient in providing explanations for the cause or
consequence of differential expression in the identified gene set.
To overcome this limitation, gene expression changes reported by
Berry et al. (2010) for 6 different conditions were integrated into the
directed network to generate response networks. These were con-
structed first by incorporating gene expression levels for each con-
dition as node weights, followed by computation of edge weights as a
function of both the node weight of connected nodes and the cor-
responding edge betweenness. We define six weighted response net-
works, each incorporating gene expression data from (a) monocytes
from healthy controls (HC_M), (b) monocytes from pulmonary
tuberculosis patients (PTB_M) (c) whole blood from healthy con-
trols (HC_B) and whole blood from tuberculosis patients monitored
through drug treatment over (d) 0 months (PTB_0), (e) 2 months
(PTB_2) and (f) 12 months (PTB_12).
Advances in microarray technology and standardisation proce-
dures have made it feasible to compare signal intensities across con-
ditions of similar samples for a given platform and chip51. Hence for
this study, the normalised signal intensity for each gene, together
with its comparative fold change were considered as opposed to fold
change alone, in order to capture relative expression levels of differ-
ent genes in a given condition, as well as their extent of change
between conditions. Constitutively expressed genes that do not vary
significantly in different conditions are also automatically captured
with this scheme. The edge weight is thus representative of both
expression values and network topology. In our scoring scheme, a
low edge weight corresponds to high expression levels of both nodes
contributing to the edge, as well as high edge centrality, thereby
indicating a higher functional importance of the edge. (Node and
edge weights for the response networks have been provided in sup-
plementary tables S2 and S1 respectively.)
The significance of changes in expression for individual nodes in
the network can be inferred better when viewed in the context of their
functional modules. Module-wise networks were constructed by
computing cumulative weights of individual nodes within the mod-
ules. Figure 2 illustrates the effects of weighting module-wise net-
works in different conditions. The module-module influence
network for the condition PTB_M, as shown in Figure 2 (a), illus-
trates the extent of modular expression for the entire network which
is the cumulative node weight of all nodes in each module, while the
edge thickness represents the extent of interaction between twomod-
ules. Figure 2 (b) and (c) provide a comparison between module
expressions in monocytes and in blood from patients over treatment
respectively. The figure illustrates that modules Phagocytosis,
Cytokine signalling, JAK-STAT signalling, TLR signalling, ROI
and SNARE have significantly higher weights in disease as compared
to healthy controls and treated samples. Antigen presentation is seen
to have a significantly lower weight in PTB_M, owing to the drastic
difference in the node weight of HLA-DRB5, with over 500 fold
decrease in expression seen in PTB_M in comparison to HC_M
(Supplementary table S2). A full list of differences inmodular expres-
sions for different module-module influence networks is given in
Supplementary tables S4 and S5.
Networkmining reveals ‘Topmost activities’ in the cell. In order to
gain insights into possible functional roles of the observed differen-
tial regulation, we implemented graph theoretical approaches to
identify connected paths of highest activities anywhere in the cell.
Identification of such paths was posed as a problem of computing
shortest paths in each of the weighted response networks. Shortest
paths among all nodes in the networks were computed using
Dijkstra’s algorithm as described in the methods section. The
algorithm finds the shortest path from a given source node to a
target node in the network by traversing edges with the lowest
edge weight. Depending on the edge weights, which are reflective
of the expression levels as well as centrality of the edge, different
routes may be taken in different response networks. We introduce
the term Path Cost which is the cumulative sum of the weights of the
edges constituting the path, described in equation (7). Lower thePath
Cost, higher is the perceived activity through that path.
Among all pair shortest paths which amount to 34,13,442 paths in
each individual response network, we considered paths of length 2
and above. We rank listed and chose top most paths by applying a
threshold derived by analysing the distributions of Path Costs of all
shortest paths (Figure 3(a)). Three cost ranges are visible in the
figure: (a) less than1, (b) costs between 1 and 2 and (c) those with
costs greater than 2. In the PTB_M network, 5862 paths appeared to
www.nature.com/scientificreports
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be of least cost (,1), amounting to 0.17% of all shortest paths in the
network, and are tagged as highest activity paths hereafter. Those
with Path Costs between 1 and 2 made up a further 0.87% and reflect
reasonably high activity paths, while those .2 are considered to be
relatively lower activity paths. Thus, the thresholds were chosen
based on the observed distribution but are still to an extent arbitrary,
erring on the side of caution so as to ensure that the selected paths are
of highest activity, while possibly allowing some high activity paths
but with higher Path Costs to bemissed out. High activity paths for all
conditions are provided in Supplementary tables S6–S11.
Module representations in the highest activity paths. In order to
observe module-wise activities in the highest activity paths, percen-
tage distribution of nodes belonging to different modules in paths
below a cost of 1 was calculated. Figure 4 shows the percentage
representation of modules in all paths below 1 for different
Figure 1 | Modelling the macrophage response in tuberculosis. (a) A molecular map describing responses triggered in the macrophage upon M.tb
infection. A singlemacrophage is reflected in green, and elicits both intracellular (outlined in green) and extracellular (outlined in purple) responses upon
encountering either complete mycobacteria or mycobacterial lipids and other components (highlighted in orange). Red arrows represent inhibitory
influences, while black arrows indicate activation. (b) Distribution of 1888 proteins in 32 biological modules participating in the cellular response
described in (a). Here, the module Cytokine shows highest representation of proteins while VEGF signalling has the least representation, in terms of
number of proteins involved in that process.
www.nature.com/scientificreports
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Figure 2 | Response networks and inter-module influences. (a) Module-module influence network for PTB_M. Node sizes are reflective of the
number of nodes and their cumulative expression in each module, while edge thickness indicates the number of influences between the connected
modules and their interaction strength. Comparative expressions of 32 modules in (b) PTB_M and HC_M and (c) different states of treatment viz.
PTB_0, PTB_2 and PTB_12 and healthy controls HC_B. In Figures 5, 6 and 7, each module is coloured differently indicated by the module labels in
Figure 2(a).
www.nature.com/scientificreports
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conditions. The figure provides a ready comparison of the various
changes that occur in ‘highest activity’ paths in monocytes from
tuberculosis patients (PTB_M) as compared to those from healthy
volunteers, as well as those activities that vary across treatment.
Several changes in PTB samples are evident from this analysis, consis-
tent in the high activity paths of both PTB_M and PTB_0 such as:
(a) significant increase in activities of modules Cytokine_signall-
ing, JAK_STAT_signalling, Lysosome, TLR_signalling, Proteasome,
Figure 3 | Path Cost distribution reveals differences in activities. (a) Path cost distribution across all 6 conditions. Paths with least cost, in the range 0–1
are considered to be of ‘highest activity’, while those in the range 1–2 are relatively ‘high activity’ paths. (b) Table showing number of paths falling
in the highest and high activity regions respectively, for all conditions.
Figure 4 | Module representation in highest activity paths. (a) Percentage representation of modules in all the highest activity (Path Costs below 1)
paths shown for monocytes in healthy conditions as well as in disease. (b) Percentage module representation in the highest activity paths upon treatment
and in healthy controls.
www.nature.com/scientificreports
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Ubiquitin_Proteolysis, RIG-I_signalling, VEGF_signalling, Cytosol_
DNA_sensing and Apoptosis (b) consistent decrease in Actin_
polymerisation, Antigen_presentation, Erb_signalling, MAPK_sig-
nalling, mTOR_signalling, SNARE, p53_signalling and Protein_pro-
cessing. In PTB_M alone, we see an increased representation of the
modules Endocytosis, Calcium_signalling, ROI and Autophagy as
compared to their healthy counterparts, while in PTB_0 we see a
higher representation of Chemokine_signalling, NOD_signalling
and PPAR_signalling, with their activities decreasing over treatment.
PPAR signalling has been shown to be exploited by M.tb to enable
survival and lead to active disease46. Some modules such as
Wnt_signalling do not show much variation in disease and healthy
conditions. Module representations in the top paths thus substantially
concur with known response profiles. Several modules are seen to
revert their activities upon treatment , similar to the activities seen
in HC_B top paths, such as JAK_STAT signalling, Cytokine signalling,
mTOR signalling and Actin polymerisation (Figure 4b), indicative of a
disease specific response which highlights the most regulated
biological modules in tuberculosis infection.
Comparison of these module activities with their node weights in
Figure 2(b) indicates that high module expression alone does not
necessarily correlate with increasedmodular activity in the top paths,
as can be seen in the resulting decrease in SNARE activity in the
PTB_M and PTB_0 top paths, despite having a higher modular node
weight in both, highlighting the importance of a network perspective
in interpreting large-scale expression data.
Broadly, all of these observations from the response networks are
consistent with knowledge from literature based on a vast number of
individual experimental studies25 and can thus be rationalised.
Module-wise analysis provides an overview of the processes occur-
ring within the cell while the actual paths provide insights into which
specific molecular events could be occurring.
Top paths themselves form connected networks. A network was
constructed using only the highest activity paths for PTB_M. 325
nodes and 501 edges from 5862 paths were seen to comprise the
PTB_M high activity network, shown in Figure 5(a) while 268
nodes and 381 edges from 2243 paths constituted the highest
activity network in HC_M (Figure 5(b)). A small fraction of the
paths (23.1%) remain common to both PTB_M and HC_M
highest activity networks, and a sub-network of paths uniquely
present in the PTB_M top network was constructed, representing
paths that are specifically activated in PTB_M. Figure 5(c) shows the
sub-network of highest activity paths unique to PTB_M, constituting
208 nodes and 286 edges.
It is intriguing to observe that the highest activity paths form well
connected networks by themselves. It must be noted that only 11% of
nodes from the complete network are involved in the uniquely active
network for PTB_M. Yet they remain well connected, implying a
smooth flow of information through these paths. The connectedness
provides a basis to understand the purpose (or consequence) of up-
regulation of a given node and how the perceived increase in activity
is transmitted to its neighbouring nodes forming a highly active path.
The PTB_M top path network is denser than the HC_M top path
network, indicating an increased upsurge in activity in disease, and
leads to the identification of participating nodes in these active paths.
It is also readily apparent from these networks that the overall extent
of activity is significantly higher in PTB than in a healthy state.
Fold change in gene expression is insufficient to convey extent of
participation in a path. On comparison of the HC_M and PTB_M
highest activity networks, 97 nodes were seen to be unique to the
PTB_M highest activity network, while 40 nodes were unique to the
HC_M top network. Interestingly, 228 nodes were seen to be
commonly occurring in both PTB_M and HC_M top networks.
Nodes occurring uniquely in the PTB_M top network showed a
range of variation in gene expression as compared to their healthy
counterparts. Of the 97 unique nodes, 62 nodes were up-regulated
(Fold change . 2) in PTB_M with high signal intensities, while the
remaining 35 nodes did not show significant variation in gene
expression between HC_M and PTB_M. Since the node weights
have been derived by considering normalised signal intensities in
addition to fold change values, they are able to reflect approximate
abundances of individual proteins. Wemust of course note that gene
expression values cannot directly be translated into protein
concentrations, but for lack of any more comprehensive quanti-
tative data for studies of this scale at present, we assume that these
expression values are reflective of protein activity in the cells.
Upon a thorough examination, it becomes apparent that the fold
change values do not by themselves reflect extent of function
mediated by that node. While the appearance of highly up-regulated
nodes in the top-activity networks can be justified, the top networks
of both HC_M and PTB_M see nodes that are constitutively
expressed in these conditions. In fact, 228 nodes are common to both
these networks, which may seem surprising at first and would have
been missed out completely by considering only the fold change
values. However, it becomes clear that these nodes, many of them
being constitutively expressed genes, form high activity bridges
between up-regulated nodes forming top scoring paths. Thus, con-
sidering DEGs alone would not be sufficient to get a network per-
spective of activities in a cell (the complete list of nodes in the top
networks for PTB_M andHC_M, along with their weights is given in
Supplementary tables S12–S14).
Nodes occurring consistently in tuberculosis networks. In order to
identify nodes appearing consistently in networks for disease, we
inspected the top-path networks over treatment. Two conditions
were considered – a) Nodes that occur in the PTB_0 top path
network and also occur uniquely in the PTB_M highest activity
network, but not in the HC_M, HC_B or PTB_12 highest activity
networks. b) Of the nodes shortlisted in a), those that show maximal
difference in their node weights in between PTB_0 and PTB_12 were
identified, suggesting that these nodes respond to treatment. By
considering the top path network for both PTB_M and PTB_0, we
extracted those nodes in the host that are significant, consistent and
specific contributors to the host’s tuberculosis response. Table 1
provides a list of these nodes showing significant differences in
node weights upon treatment, along with the corresponding
module that the node belongs to. Thus, a testable hypothesis is
obtained from this study in the form of a shortlist to be explored
as possible markers of active tuberculosis.
Network re-rerouting upon treatment- ‘Part Reversal’ to non-
infected state. One benefit of analyzing response networks in the
form of active modules is that it enables monitoring the modular
activity upon treatment. Networks corresponding to response to
treatment at 0, 2 and 12 months are constructed by incorporating
appropriate node weights obtained from gene expression profiles of
the clinical samples as reported by Berry et al. (2010). Significant
differences are indeed seen in the path activity profiles in treatment
related response networks PTB_0, PTB_2 and PTB_12. Overall, we
observe that module profiles and paths that occur in the PTB_12
networks are more similar to those in healthy controls (HC_B)
(Figure 4(b)). Many paths that were seen to emerge in PTB_0 due
to low Path Costs have reversed back to high costs upon treatment,
especially with PTB_12.
Some examples of nodes in such paths along with their immediate
neighbourhoods in different conditions are illustrated as sub-net-
works in Figure 6. Figure 6 shows an example sub-network for the
activation of IFN-c target genes PIM1, CD40 and GBP1 by IFN-c
receptors (1 and 2). IFNc-R2 appears to bemore active than IFNc-R1
in both PTB_MandPTB_0 and activates the target genes through the
JAK-STAT signalling pathway. However, in the corresponding
healthy controls, as there is no infection the IFN-c receptors and
www.nature.com/scientificreports
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Figure 5 | Highest activity paths in PTB_M and HC_M forming well connected subnets. Network of nodes and edges constituting highest activity
paths with Path Costs below 1 for (a) PTB_M and (b) HC_M. (c) A zoomed-in sub-network representing unique highest activity paths in PTB_M. Nodes
are coloured according to modules they belong to, and the edge thickness reflects the strength of the edge.
www.nature.com/scientificreports
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the target genes have very low node weights and higher edge weights,
so the algorithm takes a different, longer route through low-cost
edges while computing the optimal shortest path to the given target
genes, which may not be functionally significant as seen in paths
leading to CD40. This can be explained better in the context of
treatment, with the activity of IFN mediated responses subsiding
over the course of treatment, as the state of infection is lost,
approaching a profile similar to the healthy controls. A similar scen-
ario for differential path activity for downstream signalling through
IFNA receptors is shown. The pathways leading to the activation of
IFNA response genes GBP1, PIM1, CD40, IF130, IRF9, OAS1, IFIT2
and ISG15 show an increase in activity in PTB networks, and a
consistent decrease in path activity over the course of treatment, as
reflected by the reduction in node size and edge thickness. These sub-
networks provide a representation of the interferon response in
tuberculosis.
A detailed inspection of high activity paths in PTB_M reveals the
presence of several cytokine mediated paths as well as several highly
active paths leading to the expression of interferon-response genes.
Many of the modulators of signalling such as JAK2, STAT1, and
STAT3 are well known to be involved in regulation of the immune
system. Figure 7 provides a list of few selected paths from a given
source to a specified target that show considerably high activity in a
given condition, and their variation in Path Costs in different condi-
tions. Paths leading to antigen presentation through HLA-DRB5 are
seen to bemost repressed in PTB_M as compared to their activities in
theHC_M top path network. Subversion of antigen presentation and
expression of HLA genes is a survival strategy utilised byM.tb52. Toll
like receptors play an important role in recognition and subsequent
activation of immune responses to tuberculosis. Paths from TLR6
through MYD88 leading to TNF and IRF1 expression are active in
disease, with the activity decreasing over treatment. Downstream
responses of TNF through TNFRSF leading to GBP1 are also more
pronounced in PTB, as opposed to the healthy controls. Analysis of
top paths also reveals paths through the anti-inflammatory cytokine
IL10 in networks for disease, reflective of the intricate interplay
between both PICs andAICs. There are several other examples where
paths revert to the HC_B paths upon treatment (Supplementary
table S15). There are also examples of paths that do not completely
revert their activities upon treatment, suggesting that treatment is
effective in rescuing some but not all paths in the network
(Supplementary table S16). From this analysis we thus identified
the set of paths that respond to treatment and those that remain
relatively unchanged over the course of treatment.
Discussion
In any cell, several proteins mediate a whole range of biochemical
activities at any given time. Infection with M.tb triggers several
changes to normal cellular activity. Some of these changes may be
readily comprehensible with the available knowledge about the bio-
logy of M.tb infection, but the effect or reason of involvement of
many other proteins are yet to be understood. Most often, only those
proteins that are known to be important are focused upon leaving out
a huge number of them unaddressed. Besides gaps in knowledge of
this type, twomajor challenges in relating genotype to phenotype are
a) the scale in terms of numbers of molecular players and b) the
complexity in terms of a complex network of interactions that occur
in a cell. A wholistic systems perspective is thus necessary to not only
identify critical components but also to gain mechanistic insights
into how they achieve a particular objective. Networks of protein-
protein interactions capturing both structural (complex formation)
and functional (genetic) associations provide a useful framework to
address these aspects53,54. It is becoming increasingly feasible to con-
struct large scale networks owing to increase in the availability of
curated databases, improved cross-mapping of literature containing
primary research data into annotation databases, parseable ontolo-
gies, and cross-accession gene identifiers. There have been many
advances in network biology including improved and better access-
ible tools based on graph theoretical concepts to mine networks and
to visualize them55. It is no surprise therefore that networks are
increasingly being applied to study several complex issues including
finding hubs, choke points, shortest paths and alternate routes56.
Networks have their drawbacks as well, primarily because they pre-
sent static snapshots of cellular activities at a given instant of time. To
overcome this limitation, the concept of dynamic interactome or
response networks have been introduced18,57,58, where time or
space-series data is superimposed onto the networks to gain insights
about the changing patterns of communication within the network.
In this work, we report use of response networks in health and
disease and also upon treatment to identify top most activities in the
cell under different conditions. In a given condition, we may not
know which paths in the network are active, let alone provide a rank
list of most important activities. It is important therefore to mine all
high activity paths in an unbiased fashion. Using the response net-
works, the problem of identifying high activities in a cell can be
formulated as a problem of identifying shortest paths with least
Path Costs. A path refers to a route through a connected set of nodes
from any source to any sink. Path Cost refers to the cumulative score
of individual edges in a path. Lower the cost of the path, higher is the
Table 1 | A short list of characteristic nodes seen in tuberculosis top networks. Nodes occurring in PTB_0 and PTB_M highest activity
networks, but not in HC_M, HC_B, or PTB_12 highest activity networks that have the potential to serve as possible biomarkers for disease.
Nodes showing maximal difference in node weights upon treatment are represented here
Node Node weight PTB_0 Node weight PTB_12 Module
FCGR1A 8912.80 173.81 Phagocytosis
VAMP5 10789.79 446.83 SNARE
CASP5 877.60 56.98 Apoptosis
OAS1 680.09 50.63 Cytokine_signalling
GNG10 2343.51 243.23 Chemokine_signalling
NCF1 4405.63 689.49 ROI
IRF7 1659.32 317.85 Cytokine_signalling
IFI30 2016.60 437.90 Antigen_presentation
IRF2 144.59 47.95 Cytokine_signalling
PYCARD 2029.13 681.97 Cytosol_DNA_sensing
DUSP3 1809.13 667.71 MAPK_signalling
CCR1 777.42 323.87 Chemokine_signalling
VAMP3 1484.29 718.59 SNARE
HLA-F 3684.13 2056.94 Antigen_presentation
IRF9 3197.67 1857.75 Cytokine_signalling
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Figure 6 | Illustrative example of interferon sub-networks showing alterations in different conditions. Sub-networks are shown depicting paths from
Interferon gamma receptors and Interferon alpha receptors to downstream target genes in different conditions. Node sizes correspond to node weights,
while edge thickness reflects the interaction strength of the edge in a given condition. Nodes are coloured according to the modules they belong to.
www.nature.com/scientificreports
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Figure 7 | Path activities in different conditions. Example paths from a given source to target show variable Path Costs and thus variable activities in
different conditions. The variation in activities are demonstrated by showing the differences in weights of nodes and edges constituting the path.
Node sizes correspond to node weights, while edge thickness reflects the interaction strength of the edge in a given condition. Nodes are coloured
according to the modules they belong to.
www.nature.com/scientificreports
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activity expected through it. This formulation enables identification
of all possible paths of highest activities, anywhere in the cell. High
activity paths are those with least Path Costs which implies suffi-
ciently high levels of gene expression in that condition in all nodes
of the path and also implicitly implies that the corresponding edges
in the path are topologically centrally located. Hence the highest
activity paths identified through this method can be expected to be
significant routes through which intracellular communication can
take place.
Often for studies of this nature, a limiting factor is utilisation of
experimental data available in literature for the individual nodes in a
comprehensive manner and reconstruction of a network. We have
addressed that by first building a large curated network that captures
known biology of the individual nodes in terms of their structural
and function interactions with other proteins and includes direction
of such interactions as well as the activatory or the inhibitory nature
of the interactions.While care has been taken to include asmuch data
as presently accessible, it is inevitable that the network remains
incomplete due to lack of data for all nodes and all interactions.
However, the network model presented here allows incorporation
and refinement as new data becomes available.
Gene expression profiles through microarrays and recently also
through NextGen sequencing provide lists of differentially regulated
genes. Several reports presenting DEG profiles in tuberculosis
patients exist in literature, leading to insights into the molecular
map of the pathophysiology of tuberculosis. Many DEGs are con-
sistently identified from individual studies leading to a general pic-
ture of what changes occur in response to tuberculosis. Examples of
the identified profiles include (a) activation of cytokine signalling
including both pro-inflammatory and anti-inflammatory cytokines
(b) increased signalling through the Janus kinase signal transducer
and activator of transcription (JAK-STAT) pathway (c) increased
signalling through the Fc-gamma receptors and (d) Decrease in anti-
gen presentation indicating subversion. The network analysis
reported here identifies many of these DEGs to be present in the
top most activity paths in the network, and more importantly also
provides insights into the functional routes through which they can
mediate their altered function. We note that over-expression of a
node by itself is not a sufficient criterion for dictating ‘High
Activity’ through a given path because for an activity to take place,
the entire path must have a low Path Cost. Focusing on DEGs alone
wouldmiss out this aspect all together. Among our top activity paths,
we find some nodes which are constitutively expressed in sufficient
levels, but whose fold changemay be close to 1, for example IL10 and
IL18 are seen in high activity paths. IL10 and IL18 are both known to
play critical roles in regulating the manifestation of tuberculosis59,60.
We also observe some highly expressed DEGs such as AIM2, OSM,
VAMP5 which do not have high scoring neighbours and hence do
not feature in the top most paths. Placing them in a network per-
spective helps to understand their function in terms of their neigh-
bourhoods. Analogous to finding highways in a complex traffic
network, this approach finds top paths which are connected sets of
nodes of sufficient weights (extent of expression) and high centrality.
Validation becomes an important step in any model building
exercise. Since the network is built primarily using experimental data
based on molecular level studies of individual proteins and weighted
using experimentally derived gene expression profiles, validation will
mainly amount to checking for consistency with well known bio-
logical phenomena. This is in addition to the model building valid-
ation steps that are routinely carried out involving data accession
checks and cross-mapping across databases. Towards validation
therefore, the following were analysed (a) known nodes appearing
in the top paths, (b) checking that no inhibitory connections appear
in the top paths (edges with inhibitory connections have nodes that
are anti-correlated in their weights), (c) well known activated paths
have sufficiently low Path Costs and known repressed paths have
high costs and (d) path reversals upon treatment are seen in the
treatment related response networks. All these criteria are met for
the top paths that are analysed (Figures 6 and 7).
There are a large number of new insights that are gained from this
study including identification of connected routes for well known
nodes thus rationalising data from individual experiments. Thus, by
integrating expression data and network topology, a comprehensive
model of the host response to tuberculosis is presented. Mining the
network identifies highest activities in the cell and interestingly iden-
tifies that such top paths all form a well connected subnet. Nodes in
this network that differ substantially with respect to healthy control
and in response to treatment have the potential to serve as possible
biomarkers for tuberculosis and can be explored further for their
diagnostic potential. The approach followed is sufficiently generic
that it can be applied to other systems fairly easily, thus representing
a general framework for integrating and rationalising genome-scale
and clinical data.
Methods
The methodology comprises model building, network reconstruction, microarray
data extraction and integration into the network to generate response networks,
followed by a weighted shortest path analysis from all nodes to all other nodes in the
network and computation of Path Costs.
Model reconstruction. In the first step towards generating a response network in
macrophages, a model was built encompassing different processes that are activated in
infection as well as those responsible for cellular signalling. The model was manually
assembled after a thorough literature survey on the biology of the macrophage in
tuberculosis. The model schematic was drawn using Microsoft Visio. Modules were
identified through literature describing host cellular signalling events in tuberculosis,
as well as from pathway information sources KEGG61 and PATHWAYCOMMONS62.
Once the signalling modules were identified, all proteins that participate in or belong
to that module were enlisted using their ENTREZ identifiers.
Protein-protein interaction network. For all proteins identified in the model,
corresponding interactions were extracted and a comprehensive protein-protein
interaction network was constructed. Only interactions with experimental evidence
and supporting literature were considered. The interactions were extracted from
various sources including KEGG, STRING63, NETPATH64, Signalink65 and from the
macrophage interaction map curated by Raza and co-workers66. Through literature
survey and network repositories such as BioGRAPH67 and GeneMania68, directions
were assigned for several interactions by considering functional annotations such as
‘phosphorylation’, ‘ubiquitinylation’, ‘proteolysis’ and ‘activation’ as well as
‘inhibition’. However, for certain interactions which describe a ‘binding’ event, the
edge is represented as bidirectional. Interactions with experimental evidence but
without functional annotation were also considered as bidirectional interactions.
Ambiguous and predicted interactions were not considered.
Network Analysis. The network was subjected to network analysis using Cytoscape
version 2.8.269. Topological network properties were computed on the directed and
unweighted network, using the NetworkAnalyzer70 plugin. Shortest paths
distribution was also computed between all vertices in the network. Edge centrality
attributes, namely Edge Betweenness was calculated. Betweenness is a measure of
centrality, which captures the number of times the edge is traversed among all
shortest paths from the set of source nodes to the set of sink nodes71. For a graph
G(V,E), the edge betweenness is defined as follows:
CB eð Þ~
X
s=n=t[E
sst eð Þ
sst
ð1Þ
Where sst is the number of shortest paths from s to t, and sst(e) is the number of
shortest paths from s to t that pass through an edge e. The edge betweenness of each
edge was computed using the Cytoscape plugin NetworkAnalyzer, where the
betweenness is normalized by dividing by (M2 1)(M2 2), whereM is the number of
edges in the connected component that the edge belongs to.
Microarray data integration. For this study, microarray expression data was taken
from NCBI GEO ID GSE19491. The study was carried out by Berry et al.
(2010)8,where genome-wide whole blood transcriptional profiles were extracted from
patients with active tuberculosis and monitored under drug treatment for 0, 2 and 12
months (5 samples each), as well as healthy controls (12 samples). Neutrophils,
monocytes and CD41 and CD81 T cells were isolated. For this study, the monocyte
expression data was considered for patients with active TB(7 samples) and healthy
controls (4 samples).
Normalisation. The raw expression data was normalised per gene, as it was pre-
normalised per-chip. The expression data for the genes of interest was filtered out.
The average fold change of expression under conditions of infection in both whole
www.nature.com/scientificreports
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blood and isolated monocytes was computed with respect to the median value of the
corresponding healthy controls. The fold change for a gene i in condition A with
respect to its expression value in condition B was computed as described:
FCi(A=B)~
SignalIntensityi(A)
SignalIntensityi(B)
ð2Þ
Where SignalIntensityi(A) represents the normalised signal intensity for the condition
A and SignalIntensityi(B) represents the normalised signal intensity for the condition
B.
Node weight. For all nodes in the network, the node weight was calculated as the
product of the average fold change and the normalised signal intensity value for the
corresponding node. This captures the quantitative information regarding expression
level of the node in the cell.
The node weight Ni(A) of node i in a given condition A, is computed as:
Ni(A)~FCi(A=B)  SignalIntensityi(A) ð3Þ
Edge weight. The edge weights for every edge between two nodes were calculated by
taking into account both the nodeweights, and the betweenness of the given edge. The
edge weight was computed as the inverse of the product of edge betweenness and the
square root of the product of node weights. The edge weight in a given condition for
an edge e (We (A)) comprised of nodes Ni(A) and Nj(A) is computed by the formula:
We(A)~
1
½CB(e) 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
(Ni(A)  Nj(A)
p
) ð4Þ
Where, Ni(A) and Nj(A) are the node weights of i and j nodes respectively in condition
A. The edge weights were scaled up by 106, for convenience.
Module-module influence networks. Proteins were assigned into 32 modules based
on their presence in a given KEGG Pathway. Modular node weights Nx(A) for each
module X were calculated as a cumulative sum of node weights of individual nodes
(Ni) in the module.
NX(A)~
X
Nix(A) ð5Þ
Edge weight for an edge between module X and module Y in a condition was
calculated as
WXY(A)~
X 1
WeXY(A)
ð6Þ
where,WeXY(A) represents the edge weightWe for an edge that captures an interaction
between nodes belonging to module X and Y.
Shortest path computation. Shortest paths between all the proteins in the weighted
and directed network were computed using Dijkstra’s algorithm implemented in
MATLAB-Boost Graph Library (http://www.stanford.edu/,dgleich/programs/
matlab_bgl). The algorithm computesminimumweight shortest paths, in which each
path begins from a source node and ends with a sink node, through interacting
proteins, choosing the least-cost edge in every step. For a path of length n, the Path
Cost was computed by taking the summation of the edge weights (We(A) ) of all edges
constituting the path.
PathCost~
Xn
e~1
We(A) ð7Þ
All paths were ranked according to their PathCost, with the least costing paths ranked
highest.
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